Protagonist Therapeutics Non-Current Deferred Revenue (Quarterly) Analysis

Protagonist Therapeutics, Inc. (PTGX)

79.86 -0.36 (-0.44%) USD | NASDAQ | Jan 12, 09:57

View Non-Current Deferred Revenue (Quarterly) for PTGX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Johnson & Johnson	--
ADMA Biologics, Inc.	Upgrade
Bristol Myers Squibb Co.	Upgrade
MannKind Corp.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade